Birt-Hogg-Dubé syndrome
Updates to Article Attributes
Birt-Hogg-Dubé syndrome, BHDS or folliculin gene-associated syndrome is a multi-system disease characterised by:
- multiple lung cysts and spontaneous pneumothoraces
- renal tumours in up to 34%, most often chromophobe oncocytomas and chromophobe carcinomas which are typically slow-growing & may be multiple and bilateral13
- cutaneous manifestations: fibrofolliculomas and trichodiscomas
Epidemiology
Birt-Hogg-Dubé syndrome is rare but under-diagnosed
Diagnosis
One major criterion:
- 5 adult-onset fibrofolliculomas
- pathogenic FLCN germline mutation
2 minor criteria:
- typical
and otherwise unexplainedlung cysts with no other explanation - multifocal/bilateral renal cancer before the age of 50
- renal cancer of mixed chromophobe and oncocytic histology
- first-degree relative with BHDS
Clinical presentation
- Lung cysts
develop in early or mid adulthood pre-dating renal cancerdevelop, and are usually asymptomatic apart. Apart from a 50-foldrisk ofincrease in pneumothorax:- they are usually asymptomatic.
-
canPneumothorax can be recurrent, even bilateral -
risk factors are. Risk increases with cyst volume&and volume changes associated with flying
- 7-fold increased risk of malignancy.
- less usual histological forms should prompt a search for other features of BHD
features - chromophobe oncocytomas (50%), chromophobe carcinomas (34%), clear cell carcinomas (9%), oncocytomas (5%), papillary renal cell cancers (2%)
- frequently bilateral, multifocal, and slow growing13
Pathology
Folliculin is thought to be an oncogene suppressor protein which may affect proteolytic metalloproteinase enzymes leading to lung matrix breakdown, tissue destruction, and cyst formation.The mammalian target of rapamycin (mTOR) pathway has been implicated in the pathogenesis of BHDS 13
Genetics
Deletion mutation in the folliculin (FLCN) gene (17p11.2) with autosomal dominant inheritance. At least 142 unique DNA mutations of the FLCN gene have been implicated in the pathogenesis of BHDS, which would explain the variable features in different families 13
Radiographic features
CT
Lung cysts typically develop in early adulthood and are typically:
- multiple
,lower zone predominant and bilateral with a predilection for subpleural lung including paramediastinal and parafissural location - adjacent to interlobular septa, arteries and veins
- thin-walled, variable in size, round or elongated, multilobulated or multiseptate13.
CystsCysts adjoining the pleura may have anarrowerrelatively narrow pleural base
Treatment and prognosis
Renal tumour prognosis depends on histology. Treatment options include partial nephrectomy or ablation. Annual surveillance of adults for renal cancer is ideal and MR is the optimal imaging modality in high risk individuals.
Pneumothoraces may be prevented by cyst resection and pleurodesis.
History and etymology
It is named after Canadian physicians Arthur R Birt (dermatologist), Georgina R Hogg (pathologist) and W James Dubé (internist) who published their findings in 1978 7.
Differential diagnosis
Other causes of cystic lung disease (CLD) or focal hyperlucencies:
-
lymphangioleiomyomatosis, (LAM)
- scattered distribution, ie no spared areas
- associated with TSC or sporadic LAM (cysts develop in women during their child-bearing years)
- +/- renal angiomyolipomas & other features
specificrelated to either TSC or sLAM
-
pulmonary Langerhans cell histiocytosis
- upper zone predominant & bronchocentric cavitating nodules, branching or irregular cysts
- spares costophrenic and costomediastinal angles
- typically a disease of young adult smokers
-
lymphocytic interstitial pneumonitis
- lower zone predominant perivascular cysts which may contain internal structures
-
+/-other features of the underlying disease such as nodules, ground-glass opacity -
+/- lymphoproliferative, lymphoproliferative disease,or amyloid, -
predisposing cause such asin the case of Sjogren’s syndromeor AIDS
-
light-chain deposition disease
-
cystcysts, nodules & lymphadenopathy - older adult with multiple myeloma or macroglobulinaemia & renal failure
-
-
other cystic lung diseasesDesquamative interstitial pneumonia, pneumatocoeles, cystic pulmonary metastasesor emphysema (, alpha 1 antitrypsin deficiency, inheritedcollagen disordersconnective tissue disease such as Marfan’s syndrome,etcand neurofibromatosis type 1 (thoracic manifestations) are less likely to be confused withBHDBHDS
Practical points
Lung MinIPs help to identify lung cysts: they are more sensitive than MPRs
See also
-<p><strong>Birt-Hogg-Dubé syndrome </strong>or<strong> folliculin gene-associated syndrome</strong> is a multi-system disease characterised by:</p><ul>- +<p><strong>Birt-Hogg-Dubé syndrome, BHDS </strong>or<strong> folliculin gene-associated syndrome</strong> is a multi-system disease characterised by:</p><ul>
-<li>typical and otherwise unexplained lung cysts</li>- +<li>typical lung cysts with no other explanation </li>
-</ul><h4>Clinical presentation </h4><ul>-<li>Lung cysts<font size="1"> </font>develop in early or mid adulthood pre-dating renal cancer, and are usually asymptomatic apart from a 50-fold risk of pneumothorax:<ul>-<li>can be recurrent, even bilateral</li>-<li>risk factors are cyst volume & flying</li>-</ul>-</li>- +</ul><h4>Clinical presentation</h4><ul>
- +<li>Lung cysts develop in early or mid adulthood pre-dating renal cancer. Apart from a 50-fold increase in pneumothorax they are usually asymptomatic.</li>
- +<li>Pneumothorax can be recurrent, even bilateral. Risk increases with cyst volume and volume changes associated with flying and diving.</li>
-<li>less usual histological forms should prompt a search for other BHD features</li>- +<li>less usual histological forms should prompt a search for other features of BHD </li>
-</ul><h4><sup><strong>Pathology</strong></sup></h4><p>Folliculin is thought to be an oncogene suppressor protein which may affect proteolytic metalloproteinase enzymes leading to lung matrix breakdown, tissue destruction, and cyst formation.<sup> </sup>The mammalian target of rapamycin (mTOR) pathway has been implicated in the pathogenesis of BHDS <sup>13</sup></p><h5>Genetics</h5><p>Deletion mutation in the folliculin (<em>FLCN) </em>gene (17p11.2) with autosomal dominant inheritance. At least 142 unique DNA mutations of the FLCN gene have been implicated in the pathogenesis of BHDS, which would explain the variable features in different families <sup>13</sup></p><h4>Radiographic features</h4><h5>CT</h5><p>Lung cysts typically develop in early adulthood and are typically:</p><ul>-<li>multiple, lower zone predominant and bilateral with a predilection for subpleural lung including paramediastinal and parafissural location</li>- +</ul><h4>Pathology </h4><p>Folliculin is thought to be an oncogene suppressor protein which may affect proteolytic metalloproteinase enzymes leading to lung matrix breakdown, tissue destruction, and cyst formation.<sup> </sup>The mammalian target of rapamycin (mTOR) pathway has been implicated in the pathogenesis of BHDS <sup>13</sup></p><h4>Genetics</h4><p>Deletion mutation in the folliculin (<em>FLCN) </em>gene (17p11.2) with autosomal dominant inheritance. At least 142 unique DNA mutations of the FLCN gene have been implicated in the pathogenesis of BHDS, which would explain the variable features in different families <sup>13</sup></p><h4>Radiographic features</h4><h5>CT</h5><p>Lung cysts typically develop in early adulthood and are typically:</p><ul>
- +<li>multiple lower zone predominant and bilateral with a predilection for subpleural lung including paramediastinal and parafissural location</li>
-<li>thin-walled, variable in size, round or elongated, multilobulated or multiseptate<sup>13. </sup>Cysts adjoining the pleura may have a narrower pleural base</li>-</ul><h4>Treatment and prognosis</h4><h4>History and etymology</h4><p>It is named after Canadian physicians <strong>Arthur R Birt </strong>(dermatologist), <strong>Georgina R Hogg</strong> (pathologist) and <strong>W James Dubé</strong> (internist) who published their findings in 1978 <sup>7</sup>.</p><h4>Differential diagnosis</h4><p>Other causes of cystic lung disease (CLD) or focal hyperlucencies:</p><ul>- +<li>thin-walled, variable in size, round or elongated, multilobulated or multiseptate<sup>13</sup>. Cysts adjoining the pleura may have a relatively narrow pleural base</li>
- +</ul><h4>Treatment and prognosis</h4><p>Renal tumour prognosis depends on histology. Treatment options include partial nephrectomy or ablation. Annual surveillance of adults for renal cancer is ideal and MR is the optimal imaging modality in high risk individuals.</p><p>Pneumothoraces may be prevented by cyst resection and pleurodesis.</p><h4>History and etymology</h4><p>It is named after Canadian physicians <strong>Arthur R Birt </strong>(dermatologist), <strong>Georgina R Hogg</strong> (pathologist) and <strong>W James Dubé</strong> (internist) who published their findings in 1978 <sup>7</sup>.</p><h4>Differential diagnosis</h4><p>Other causes of cystic lung disease or focal hyperlucencies:</p><ul>
-<li>+/- renal angiomyolipomas & features specific to TSC or sLAM</li>- +<li>+/- renal angiomyolipomas & other features related to either TSC or sLAM</li>
-<a title="pulmonary Langerhans cell histiocytosis" href="/articles/pulmonary-langerhans-cell-histiocytosis">p</a><a title="Pulmonary Langerhans cell histiocytosis" href="/articles/pulmonary-langerhans-cell-histiocytosis">ulmonary </a><a title="Langerhans cell histiocytosis" href="/articles/pulmonary-langerhans-cell-histiocytosis">Langerhans cell histiocytosis</a><ul>-<li>upper zone predominant & bronchocentric cavitating nodules, branching or irregular cysts </li>- +<a href="/articles/pulmonary-langerhans-cell-histiocytosis">p</a><a href="/articles/pulmonary-langerhans-cell-histiocytosis">ulmonary </a><a href="/articles/pulmonary-langerhans-cell-histiocytosis">Langerhans cell histiocytosis</a><ul>
- +<li>upper zone predominant & bronchocentric cavitating nodules, branching or irregular cysts</li>
-<li>lower zone predominant perivascular cysts which may contain internal structures </li>-<li>+/- nodules, ground-glass opacity </li>-<li>+/- lymphoproliferative disease, amyloid,</li>-<li>predisposing cause such as Sjogren’s syndrome or AIDS</li>- +<li>lower zone predominant perivascular cysts which may contain internal structures</li>
- +<li>other features of the underlying disease such as nodules, ground-glass opacity, lymphoproliferative disease or amyloid in the case of Sjogren’s syndrome</li>
-<a title="light-chain deposition disease" href="/articles/light-chain-deposition-disease">light-chain deposition disease</a><ul>-<li>cyst, nodules & lymphadenopathy</li>- +<a href="/articles/light-chain-deposition-disease">light-chain deposition disease</a><ul>
- +<li>cysts, nodules & lymphadenopathy</li>
-<li>other cystic lung diseases, <a title="pneumatocoeles" href="/articles/pneumatocoeles">pneumatocoeles</a>, cystic metastases or emphysema (<a title="alpha 1 antitrypsin deficiency" href="/articles/alpha-1-antitrypsin-deficiency-4">alpha 1 antitrypsin deficiency</a>, inherited collagen disorders such as Marfan’s syndrome, etc) are less likely to be confused with BHD </li>- +<li>
- +<a title="Desquamative interstitial pneumonia" href="/articles/desquamative-interstitial-pneumonia">Desquamative interstitial pneumonia</a>, <a href="/articles/pneumatocoeles">pneumatocoeles</a>, <a title="cystic pulmonary metastases" href="/articles/cystic-pulmonary-metastases">cystic pulmonary metastases</a>, <a href="/articles/alpha-1-antitrypsin-deficiency-4">alpha 1 antitrypsin deficiency</a>, inherited connective tissue disease such as <a title="Marfan’s syndrome" href="/articles/marfan-s-syndrome">Marfan’s syndrome</a>, and <a title="neurofibromatosis type 1 (thoracic manifestations)" href="/articles/neurofibromatosis-type-1-thoracic-manifestations-1">neurofibromatosis type 1 (thoracic manifestations)</a> are less likely to be confused with BHDS</li>